biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > beenthere Responds to My Post

<< Previous

Bullboard Posts

Next >>

Comment by TheTruth1234on Aug 24, 2023 12:13am

96 Views

Post# 35603135

RE:RE:RE:RE:RE:RE:RE:beenthere Responds to My Post

Boomskid wrote: Come on, TT Sappy Cap.

Get a mitt and get in the game.

We're just getting started tonight.

What was the play?

If LT and The gang didn't want xB3, what was their play?

What were they going to get out of it?

jd